North American Business Opportunities

Partnering with Apotex – North America
One in five pharmaceutical prescriptions in Canada is filed with an Apotex product, making us a market share leader in the region. In the USA, for the products which Apotex competes in, we have +30% market share.
If you are a pharmaceutical company engaged in the following pharmaceutical development programs Apotex aspires to become your Partner of Choice and wants to hear from you.
Early-to-market and limited competition opportunities
- first-to-file/ race-to-market
- non-infringing API and/or formulations
- NCE-1s
- Currently approved and/or filed products
- Contract development and/or manufacturing
- New Technologies
Inhalation
- Dry Powder Inhalers
- Metered Dose Inhalers
Injectables
- Nano particles
- Carbapenems
- Depots/ Long Acting injectables
- Hormones
- Liposomal
- Peptides
- Lyophilized
- Penicillins
- Semi-Synthetic Penicillins
Topicals
- Creams
- Gels
- Ointments
- Lotions
Ophthalmics
- Ointments and gels
Orals
- Scheduled products
- Orodispersable
- Hormones
- Buccal/transmucosals
- Soft and Hard gelatin capsules
Over-the-counter (OTC) products